Found 18 matching trials
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer PHASE2 To evaluate the efficacy and safety of rezvilutamide in combination with an...
Show More Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Learn More & Join Trial
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma PHASE2 The purpose of the study is to evaluate the efficacy and safety of rezvilut...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy PHASE2 Prostate cancer patients with high-risk features who undergo radical prosta...
Show More Location
Nanjing Drum Tower Hospital, Affilitated Hospital of Medical School, Nanjing University
Learn More & Join Trial
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC PHASE2 This multi-center randomized controlled phase II trial was carried out in s...
Show More Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Learn More & Join Trial
Rezvilutamide for High-Risk Prostate Cancer After Surgery NA The goal of this clinical trial is to learn if Rezvilutamide works to treat...
Show More Location
Department of Urology, Fujian Union Hospital, Fujian Medical University
Learn More & Join Trial
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients PHASE3 To evaluate: The radiographic progression-free survival (rPFS) of metastati...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer PHASE2 To evaluate the efficacy and safety of rezvilutamide in combination with an...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC. N/A This multicenter retrospective study developed and validated a prediction m...
Show More Location
The First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer N/A This study aims to assess the impact of Androgen Deprivation Therapy (ADT) ...
Show More Location
The Third Affiliated Hospital of Soochow University
Learn More & Join Trial
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer PHASE3 This study aims to compare the efficacy and safety of rezvilutamide with en...
Show More Location
The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital
Learn More & Join Trial